Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer

European Journal of Cancer Part A

Volumn 32, Issue 8, 1996, Pages 1320-1324

  Sagaster, P ^a   Flamm, J ^b   Flamm, M ^b   Mayer, A ^a   Donner, G ^b   Oberleitner, S ^b   Havelec, L ^c   Lepsinger, L ^b   Ludwig, H ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b GENERAL HOSPITAL   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Downstaging; Muscle invasive bladder cancer; Neoadjuvant chemotherapy

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA; TRANSURETHRAL RESECTION;

EID: 0030056685     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00114-1     Document Type: Article

References (20)

1. UICC (Union International contre le cancer 1978). Bladder (ISD-0 188). In Harmer MH, ed. TNM classification of Malignant Tumours. Geneva, UICC, Berlin, Heidelberg, Springer-Verlag, 1978, 113-115.
2. Hauptmann RE, Miller K, Steiner K, et al. The ileal neobladder. 6 years of experience with more than 200 patients. J Urol 1993, 150, 40-45.
3. Herr HW, Whitmore WF Jr, Morse MJ, Sogani PC, Russo P, Fair WR. Neoadjuvant chemotherapy in invasive bladder cancer. The evolving role of surgery. J Urol 1990, 144, 1083-1088.
4. DeKernion JB, Abi-Aad A, Figlin R, Stenzl A. Long term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma (TCC) of the bladder. J Urol 1992, 147, 447A (abstract).
5. Seidman AD, Scher HI, Herr H, et al. Survival analysis: neoadjuvant methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy in muscle-invasive bladder cancer. J Urol 1992, 147, 444A (abstract).
6. Rintala E, Hannisdal E, Fossa SD, et al. Neoadjuvant chemotherapy in bladder cancer: a randomized study. Scand J Uro Nephrol 1993, 27, 355-362.
7. Hall RR, Parmar MKB. Randomised intercontinental retrospective study of locoregional therapy with or without neoadjuvant chemotherapy. In Splinter TAW, Scher HI, eds. Neoadjuvant Chemotherapy in Invasive Bladder Cancer. Progress in Clinical and Biological Research. New York, Wiley-Liss, 1990, 353, 105-109.
8. Crawford ED, Natale RB, Burton H. Southwest Oncology Group Study 8710: retrospective study of cystectomy alone versus neoadjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup retrospective study 0080). In Splinter TAW, Scher HI, eds. Neoadjuvant Chemotherapy in Invasive Bladder Cancer. Progress in Clinical and Biological Research. New York, Wiley-Liss, 1990, 353, 111-113.
9. Sternberg CN, Yagoda A, Scher HI, et al. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional call carcinoma of urothelium. J Urol 1988, 139, 461-469.
10. Herr HW. Conservative management of muscle-infiltrating bladder cancer; prospective experience. J Urol 1987, 138, 1162-1163.
11. Sternberg CN, Arena MG, Calabresi F, et al. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder. Cancer 1993, 72, 1975-1982.
12. Srougi M, Simon SD. Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and bladder preservation in locally invasive bladder cancer: a 5-year follow-up. J Urol 1994, 151, 593-597.
13. Vogelzang NJ, Moormeier JA, Awan AM, et al. Methotrexate, vinblastin, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience. J Urol 1993, 149, 753-757.
14. Herr HW, Scher HI. Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J Clin Oncol 1994, 12, 975-980.
15. Kaufman DS, Shipley WU, Griffin PP, Heney NM, Althausen AF, Efird JT. Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 1993, 329, 1377-1382.
16. Herr HW. Staging invasive bladder cancer. J Surg Oncol 1992, 51, 217-220.
17. Splinter TAW, Scher HI, Denis L, et al. The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. J Urol 1992, 147, 606-608.
18. Schultz PK, Herr HW, Zhang ZF, et al. Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. J Clin Oncol 1994, 12, 1394-1401.
19. Parmar MK. Neoadjuvant chemotherapy in invasive bladder cancer. Retrospective study design. Prog Clin Biol Res 1990, 353, 115-118.
20. Hatcher PA, Hahn RG, Richardson RL, Zincke H. Neoadjuvant chemotherapy for invasive bladder carcinoma: disease outcome and bladder preservation and relationship to local tumour response. Eur Urol 1994, 25, 209-215.